BRC No. | Strain name | Strain type | Research application |
---|---|---|---|
RBRC09422 | FVB.129S6-Gt(ROSA)26Sor<tm1(Pik3ca*E545K)Egan> | Targeted Mutation | Cancer Research Cre/loxP system |
RBRC09663 | FVB.MSM-(D7Mit351) | Congenic | Cancer Research Dermatology Research |
RBRC09664 | FVB.MSM-(D7Mit351-D7Mit149) | Congenic | Cancer Research Dermatology Research |
RBRC09696 | C57BL/6J-Tg(SFTPC-CD74/ROS1)125Tno | Transgene | Cancer Research |
RBRC09697 | C57BL/6J-Tg(SFTPC-SDC4/ROS1)141Tno | Transgene | Cancer Research |
RBRC09702 | B6.129-Mta1<tm1Nkcc> | Targeted Mutation | Cancer Research |
RBRC09703 | B6.129-Mta2<tm1Nkcc> | Targeted Mutation | Cancer Research |
RBRC09730 | B6.Cg-Braf<tm1Tumg> | Targeted Mutation | Cancer Research Cell Biology Research Cre/loxP system FLP/frt system Mouse Models for Human Disease |
RBRC09731 | ICR.Cg-Braf<tm1.1Tumg> | Targeted Mutation | Cancer Research Cell Biology Research Cre/loxP system Mouse Models for Human Disease |
RBRC09907 | 129.Cg-Braf<tm1Tumg> | Targeted Mutation | Cancer Research Cre/loxP system FLP/frt system |
RBRC10003 | ICR;Cg-Hsf1<tm1Anak> | Targeted Mutation | Cancer Research Neurobiology Research |
RBRC10023 | C57BL/6-Tg(Ly6a-APOBEC3B<*>v1)5Fscr | Transgene Congenic | Cancer Research |
RBRC10024 | C57BL/6-Tg(Ly6a-APOBEC3B<*>v1)7Fscr | Transgene Congenic | Cancer Research |
RBRC10044 | B6(D2)-Sufu<Rgsc1185> | Chemically-induced Mutation | Cancer Research Developmental Biology Research |
RBRC10045 | B6(D2)-Sufu<Rgsc2027> | Chemically-induced Mutation | Cancer Research Developmental Biology Research |
RBRC10046 | B6(D2)-Sufu<Rgsc2029> | Chemically-induced Mutation | Cancer Research Developmental Biology Research |
RBRC10047 | B6(D2)-Sufu<Rgsc2070> | Chemically-induced Mutation | Cancer Research Developmental Biology Research |
RBRC10048 | B6(D2)-Sufu<Rgsc2071> | Chemically-induced Mutation | Cancer Research Developmental Biology Research |
RBRC10368 | B6.129P2-Pin1<tm1Tuc> | Targeted Mutation | Cancer Research Cardiovascular Research Cre/loxP system Diabetes and Obesity Research Immunology and Inflammation Research covid19_progression |
RBRC10458 | MSM-Cdkn2a<em1Arak>/Yuwa | CRISPR/Cas9 | Cancer Research |
RBRC10459 | MSM-Del(4D4Mit26-D4Mit165)67Arak/Yuwa | CRISPR/Cas9 (Transgene) | Cancer Research |
RBRC10460 | MSM-Del(4D4Mit327-D4Mit301)33Arak/Yuwa | CRISPR/Cas9 (Transgene) | Cancer Research |
RBRC10461 | MSM-Del(4D4Mit327-D4Mit301)29Arak/Yuwa | CRISPR/Cas9 (Transgene) | Cancer Research |
RBRC10475 | 129/Sv-+/ter(Hi) | Spontaneous Mutation | Cancer Research |
RBRC10476 | LTXBJ-ett1/ett1 | Spontaneous Mutation Congenic | Cancer Research |
RBRC10481 | B6.Cg-Pkm<tm1Ntan> | Targeted Mutation | Cancer Research Metabolism Research |
RBRC10482 | C57BL/6-Pkm<tm3Ntan> | Targeted Mutation | Cancer Research Metabolism Research |
RBRC10866 | B6.Cg-Hras<tm1.1(G12S)Tumg> | Targeted Mutation | Apoptosis Research Cancer Research Cardiovascular Research Cre/loxP system Hematological Research Metabolism Research Mouse Models for Human Disease |
RBRC10904 | 129.Cg-Tg(Th-MYCN)41WawKkad | Transgene | Cancer Research |
RBRC11670 | C57BL/6J-Rassf6<em1Kymt> | CRISPR/Cas9 | Apoptosis Research Cancer Research Cell Biology Research Developmental Biology Research |